Citigroup Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $46

Benzinga · 2d ago
Citigroup analyst Yigal Nochomovitz initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $46.